EMPLOYMENT AGREEMENTEmployment Agreement • November 9th, 2012 • Aegerion Pharmaceuticals, Inc. • Pharmaceutical preparations • Massachusetts
This Employment Agreement (this “Agreement”) is made and entered into as of this 7th day of November 2011, by and between Aegerion Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Craig E. Fraser (the “Employee”).
FIRST LOAN MODIFICATION AGREEMENTFirst Loan Modification Agreement • November 9th, 2012 • Aegerion Pharmaceuticals, Inc. • Pharmaceutical preparations
This First Loan Modification Agreement (this “Loan Modification Agreement”) is entered into as of July 10, 2012, by and between SILICON VALLEY BANK, a California corporation, with its principal place of business at 3003 Tasman Drive, Santa Clara, California 95054 and with a loan production office located at 275 Grove Street, Suite 2-200, Newton, Massachusetts 02466 (“Bank”) and AEGERION PHARMACEUTICALS, INC., a Delaware corporation with its chief executive office located at 101 Main Street, Suite 1850, Cambridge, Massachusetts 02142(“Borrower”).
SECOND AMENDMENT TO LEASELease • November 9th, 2012 • Aegerion Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
THIS SECOND AMENDMENT TO LEASE, dated as of September 4, 2012 (this “Amendment”), between RREEF AMERICA REIT II CORP. PPP, a Maryland corporation (“Landlord”), and AEGERION PHARMACEUTICALS, INC. a Delaware corporation (“Tenant”), for certain premises located in the building in Riverfront Office Park at 101 Main Street, Cambridge, Massachusetts (“Building”).
